Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (353)
  2. Haematologica Meeting Reports (4)

Results (357)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia
    Journal Article

    Coombs, C. C.; Sallman, D. A.; Devlin, S. M.; Dixit, S.; Mohanty, A.; Knapp, K.; Al Ali, N. H.; Lancet, J. E.; List, A. F.; Komrokji, R. S.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: Prognostic significance of measurements in the coronal and transverse planes
    Journal Article

    Kumar, A.; Burger, I. A.; Zhang, Z.; Drill, E. N.; Migliacci, J. C.; Ng, A.; LaCasce, A.; Wall, D.; Witzig, T. E.; Ristow, K.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Donor and recipient sex in allogeneic stem cell transplantation: What really matters
    Journal Article

    Kim, H. T.; Zhang, M. J.; Woolfrey, A. E.; St. Martin, A.; Chen, J.; Saber, W.; Perales, M. A.; Armand, P.; Eapen, M.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Bone disease in monoclonal gammopathy of undetermined significance: Results from a screened population-based study
    Meeting Abstract

    Thorsteinsdottir, S.; Lund, S. H.; Lindqvist, E.; Sigurdsson, G.; Costello, R.; Burton, D.; Steingrimsdottir, H.; Launer, L. J.; Gudnason, V.; Eiriksdottir, G.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Impact of family history on risk of progression of MGUS to multiple myeloma: A population-based study
    Meeting Abstract

    Aradottir, K.; Lund, S. H.; Landgren, O.; Bjorkholm, M.; Turesson, I.; Kristinsson, S. Y.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Dietary habits across the lifespan and risk of monoclonal gammopathy of undetermined significance: A population based screening study
    Meeting Abstract

    Thordardottir, M.; Lindqvist, E.; Lund, S.; Costello, R.; Torfadottir, J.; Burton, D.; Steingrimsdottir, L.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Diagnosis, prognosis and risk assessment of multiple myeloma: Identifying gaps and addressing education needs for hematologists and oncologists
    Meeting Abstract

    Van Laar, E.; Fagerlie, S.; Landgren, O.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Patterns of idelalisib treatment-emergent lymphocytosis in patients with CLL or SLL
    Meeting Abstract

    Ghia, P.; Cheson, B. D.; Furman, R. R.; Hallek, M.; Hillmen, P.; O'Brien, S. M.; Sharman, J. P.; Dubowy, R. L.; Velasco, B.; Waldapfel, C. C.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Phase 1 final results and phase 2a dose selection for cerdulatinib (Prt062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P.; Flinn, I.; Wagner-Johnston, N.; Burger, J.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G.; Leeds, J.; Sabalvaro-Torres, A.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Comparison of pace clinical trial vs real-world ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: